[CBA-200] Angiogenesis Assay 요약정보 및 구매

50 assays

상품 선택옵션 0 개, 추가옵션 0 개

제조사 CellBiolabs
납기일 2-3 주
판매가격 765,000원
포인트 0점(구매금액 : 0%)
배송비결제 3,500원   (주문금액 10만원 이상일시 배송비 무료)

선택된 옵션

  • [CBA-200] Angiogenesis Assay (+0원)

상품 정보

상품 기본설명

50 assays

상품 상세설명

CBA-200_0.jpg

  • Assesses angiogenic tube formation in vitro
  • Uses an ECM matrix gel
  • Resembles in vivo basement membrane environment

 

 

Endothelial Tube Formation Assay (In Vitro Angiogenesis)
Catalog Number
CBA-200
Size
50 assays
Detection
Light Microscopy
Manual/Data SheetDownload
SDSDownload

 

 

Product Details

For angiogenesis to occur, endothelial cells must escape their stable location and break through the basement membrane. Cells migrate toward an angiogenic stimulus that may be released from nearby tumor cells. These cells proliferate to form new blood vessels.

Our Endothelial Tube Formation Assay (In Vitro Angiogenesis) provides an easy, robust system to assess angiogenesis in vitro. The ECM gel matrix very closely resembles an in vivo environment.

CBA-200%20Fig%201.jpg

HUVEC Tube Formation on ECM Gel. HUVEC cells from a standard tissue culture plate were incubated on an ECM gel. After several hours, tube formation can be visualized under a light microscope.

Recent Product Citations
  1. Lee, S.I. et al. (2016). Baicalein promotes angiogenesis and odontoblastic differentiation via the BMP and Wnt pathways in human dental pulp cells. Am. J. Chinese Med44:1457.
  2. Yun, H.M. et al. (2016). Magnetic nanofiber scaffold-induced stimulation of odontogenesis and pro-angiogenesis of human dental pulp cells through Wnt/MAPK/NF-κB pathways. Dent Materdoi:10.1016/j.dental.2016.06.016.
  3. Qiu, D. et al. (2016). Overexpression of FoxP1 is a novel biomarker of malignant human pancreatic cancer. Int J Clin Exp Med. 9:9054-9063.
  4. Pekozer, G. G. et al. (2016). Influence of co-culture on osteogenesis and angiogenesis of bone marrow mesenchymal stem cells and aortic endothelial cells. Microvasc Res. doi:10.1016/j.mvr.2016.06.005.
  5. Sun, Y. et al. (2016). Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling. ExpCell Resdoi:10.1016/j.yexcr.2016.07.009.
  6. Bid, H. K. et al. (2016). The Bromodomain BET inhibitor JQ1 suppresses tumor angiogenesis in models of childhood sarcoma. Mol Cancer Ther. doi:10.1158/1535-7163.
  7. Yun, H. M. et al. (2016). Magnetic nanocomposite scaffolds combined with static magnetic field in the stimulation of osteoblastic differentiation and bone formation. Biomaterials. 85:88-98.
  8. Chang, S. W. et al. (2016). Combined effects of mineral trioxide aggregate and human placental extract on rat pulp tissue and growth, differentiation and angiogenesis in human dental pulp cells. Acta Odontol Scanddoi:10.3109/00016357.2015.1120882.
  9. Sun, T. et al. (2016). Forkhead box protein k1 recruits TET1 to act as a tumor suppressor and is associated with MRI detection. Jpn J Clin Oncol. doi:10.1093/jjco/hyv185.
  10. Al-Mahrouki, A. A. et al. (2015). Ultrasound-stimulated microbubble enhancement of radiation treatments: endothelial cell function and mechanism.Oncoscience.2:944-957.
  11. Chang, S. W. et al. (2015). Odontoblastic differentiation, inflammatory response, and angiogenic potential of 4 calcium silicate–based cements: MicroMega MTA, ProRoot MTA, Retro MTA, and experimental calcium silicate cement. Endod. doi: 10.1016/j.joen.2015.04.018.
  12. Zheng, D. et al. (2015). Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice. Diabetologia.  doi: 10.1007/s00125-015-3622-8.
  13. Yamanegi, K. et al. (2015). Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells. Int J Oncoldoi: 10.3892/ijo.2015.2924. 
  14. Bae, W. J. et al. (2015). Effects of sodium tri-and hexametaphosphate on proliferation, differentiation, and angiogenic potential of human dental pulp cells. Endod. doi: 10.1016/j.joen.2015.01.038.
  15. Zhang, J. et al. (2015). Effects of bioactive cements incorporating zinc-bioglass nanoparticles on odontogenicand angiogenic potential of human dental pulp cells. Biomater Appl. 29:954-964.
  16. Pessôa, B. S. et al. (2015). Effect of a stable angiotensin-(1–7) analogue on progenitor cell recruitment and cardiovascular function post myocardial infarction. J Am Heart Assoc. doi: 10.1161/JAHA.114.001510.
  17. Hutzen, B. et al. (2014). Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatinBMC Cancer. 14:206.
  18. El Kaffas, A. et al. (2014). Sunitinib effects on the radiation response of endothelial and breast tumor cells. Microvasc Res.  92:1-9.
  19. Lee, S. J. et al. (2014). Statins3-hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors, Potentiate the Anti-Angiogenic Effects of Bevacizumab by Suppressing Angiopoietin2BiP, and Hsp90α in Human Colorectal Cancer Br J Cancer111-497-505.
  20. Shin, M.R. et al. (2014). TNF-α and LPS Activate Angiogenesis via VEGF and SIRT1 Signalling in Human Dental Pulp Cells. Int Endod J. 10.1111/iej.12396.
  21. Edwards, A.K. et al. (2014).  A peptide inhibitor of synuclein-greduces neovascularization of human endometriotic lesions.  Mol Hum Reprod20:1002-1008.
  22. Cai, X. et al. (2013). Serum Amyloid A Stimulates Cultured Endothelial Cells to Migrate and Proliferate: Inhibition by the Multikinase Inhibitor BIBF1120Clin Exp Pharmacol Physiol40:662-670.
  23. Yu, J.G. et al. (2013). Baroreflex Deficiency Hampers Angiogenesis After Myocardial Infarction via acetylcholine-α7-nicotinic ACh Receptor in Rats. Eur. Heart J. 34:2412-2420.
  24. Bid, H. et al. (2013). Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy. Clin. Cancer Res19: 2984-2994.
  25. Cai, C. et al. (2012). SIVmac239-Nef Down-regulates Cell Surface Expression of CXCR4 in Tumor Cells and Inhibits Proliferation, Migration and AngiogenesisAnitcancer Res. 23:2759-2768.
  26. Bid, H. et al. (2012). Potent Inhibition of Angiogenesis by the IGF-1 Receptor-Targeting Antibody SCH717454 Is Reversed by IGF-2Mol. Cancer Ther11: 649-659.
  27. Spencer, M. et al. (2011). Adipose Tissue Extracellular Matrix and Vascular Abnormalities in Obesity and Insulin Resistance. Clin Endocrinol Metab96:E1990-1998.
  28. Wang, C. et al. (2010). Rosuvastatin, Identified from a Zebrafish Chemical Genetic Screen for AntiangiogenicCompounds, Suppresses the Growth of Prostate Cancer. Eur Urol58:418-426.
  29. Weskamp, G. et al. (2010). Pathological Neovascularization is Reduced by Inactivation of ADAM17 in Endothelial Cells but Not in PericytesCirc. Res. 106:932-94.
  30. Hirata, H. et al. (2010). Role of Secreted Frizzled-Related Protein3 in Human Renal Cell Carcinoma. Cancer Res. 70:1896-1905.
  31. Alfano, R.W. et al. (2009). Matrix Metalloproteinase-Activated Anthrax Lethal Toxin Inhibits Endothelial Invasion and Neovasculature Formation During In Vitro MorphogenesisMol. Cancer Res. 7:452-461.
  32. Nogueras, S. et al. (2008). Coupling of Endothelial Injury and Repair. An Analysis Using an In Vivo Experimental mMdelAm J. Physiol Heart Circ Physiol 294:H708-H713.
  33. Masamune, A. et al. (2008). Hypoxia Stimulates Pancreatic Stellate Cells to Induce Fibrosis and Angiogenesis in Pancreatic Cancer. Am. J. PhysiolGastrointest. Liver Physiol. 295:G709-G717.
  34. Zou, L. et al. (2007). Rapid Xenograft Tumor Progression in Beta-Arrestin1 Transgenic Mice Due to Enhanced Tumor AngiogenesisFASEB J. 22:355-364.

 

 

상품문의

등록된 상품문의

상품문의가 없습니다.

반품/교환정보

셀젠바이오샵에서는 다음과 같은 기간 및 내용으로 상품에 대하여 교환, 반품, 환불을 보장하고 있으며, 상품의 반환에 의한

추가비용을 고객에게 부담시지키 않습니다. (, 고객 변심 또는 주문 반복으로 인한 경우의 반환비용은 고객님이 부담하셔야

합니다.)

 

::: 교환 및 반품이 가능한 경우:::

-상품을 공급 받으신 날로부터 7일 이내

  , 상품을 개봉하여 상품가치가 상실된 경우에는 교환/반품이 불가능합니다.

-공급받으신 상품 및 용역의 내용이 표시, 광고 내용과 다르거나 다르게 이행된 경우
-

:::교환 및 반품이 불가능한 경우:::

-하자가 없는 상품을 택배사로부터 인도 받으신 날로부터 20일 이후.
- 고객님의 책임 있는 사유로 상품등이 멸실 또는 훼손된 경우.
- 포장을 개봉하였거나 포장이 훼손되어 상품가치가 현저히 감소한 경우
- 시간의 경과에 의하여 재판매가 곤란할 정도로 상품등의 가치가 현저히 감소한 경우
- 주문 당시 해외 발주 상품의 경우
-

주문 취소 및 반품으로 환불을 요청하실 경우에는 E-mail(celgen-bio@celgen-bio.com)이나 고객만족센터 (042-824-9026)

통해 요청하시면 친절하게 처리해 드리겠습니다.

주문 취소 후 반품 가능 여부를 확인한 다음 3일 이내에 결제 금액을 환불해 드리겠습니다.
  • ㈜셀젠바이오테크, 대표자명: 김성빈, 사업자등록번호: 344-08-00018, 통신판매업종 제 2017-대전유성-0220 호
  • 대전광역시 대덕구 대화로69, 3층(대화동)
  • 대표전화: 042-824-9026 팩스: 042-824-9027
  • E-Mail: celgen-bio@celgen-bio.com
  • Copyright © 2015 Celgen-Bio.tech All rights reserved.